Detection and Biological Characteristic of FLT3 Gene Mutations in Children with Acute Leukemia

被引:0
作者
Nasiri, Nahid [1 ]
Shaikhy, Maryam [2 ]
Zaker, Farhad [1 ,3 ]
Hosseini, Soudabeh [1 ]
Moosavi, Seyed Akbar [4 ]
Marjani, Abdol Jalal [5 ]
机构
[1] Iran Univ Med Sci, Dept Hematol, Sch Allied Med, Tehran, Iran
[2] Islamic Azad Univ, Dept Sci & Res, Tehran, Iran
[3] Iran Univ Med Sci, Cellular & Mol Res Ctr, Tehran, Iran
[4] Iran Univ Med Sci, Dept Lab Sci, Sch Allied Med, Tehran, Iran
[5] Golestan Univ Med Sci, Gorgan Fac Med, Dept Biochem, Gorgan, Iran
关键词
Acute leukemia; Flt3-ITD; PCR-RFLP; ACUTE MYELOID-LEUKEMIA; INTERNAL TANDEM DUPLICATION; CONSTITUTIVE ACTIVATION; CELL-GROWTH; C-KIT; KINASE; FMS; ASSOCIATION; EXPRESSION; PROGNOSIS;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: FLT3 ITD and D835 mutations occur in high frequency in AML and to a lower rate in ALL patients with poor prognosis. Methods: ITD and D835 mutations were studied in 100 diagnosed acute leukemia patients including 27 AML and 73 ALL with various FAB classifications by PCR and PCR-RELP, respectively. Subsequently, PCR products of positive samples were confirmed by sequencing analyses. Results: ITD mutations occurred in 10% of all pediatric acute leukemia, including AML and ALL. 25.9% of AML patients harbor a mutation in the ITD in various subtypes. The frequency of ITD mutations was 4% in ALL. Various insertions of nucleotides in ITD were observed, similar to those described in the literature previously. Conclusion: These preliminary data suggest that flt3-ITD mutations may play an important role in leukemogenesis in a proportion of children, particularly in the case of AML.
引用
收藏
页码:258 / 261
页数:4
相关论文
共 34 条
  • [1] FLT3 internal tandem duplication mutations in adult acute myeloid leukaemia define a high-risk group
    Abu-Duhier, FM
    Goodeve, AC
    Wilson, GA
    Gari, MA
    Peake, IR
    Rees, DC
    Vandenberghe, EA
    Winship, PR
    Reilly, JT
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2000, 111 (01) : 190 - 195
  • [2] FLT3 mutations in childhood acute lymphoblastic leukemia
    Armstrong, SA
    Mabon, ME
    Silverman, LB
    Li, AH
    Gribben, JG
    Fox, EA
    Sallan, SE
    Korsmeyer, SJ
    [J]. BLOOD, 2004, 103 (09) : 3544 - 3546
  • [3] THE EXPRESSION OF FMS, KIT AND FLT3 IN HEMATOPOIETIC MALIGNANCIES
    BIRG, F
    ROSNET, O
    CARBUCCIA, N
    BIRNBAUM, D
    [J]. LEUKEMIA & LYMPHOMA, 1994, 13 (3-4) : 223 - 227
  • [4] Pediatric AML primary samples with FLT3/ITD mutations are preferentially killed by FLT3 inhibition
    Brown, P
    Meshinchi, S
    Levis, M
    Alonzo, TA
    Gerbing, R
    Lange, B
    Arceci, R
    Small, D
    [J]. BLOOD, 2004, 104 (06) : 1841 - 1849
  • [5] Incidence and prognosis of c-KIT and FLT3 mutations in core binding factor (CBF) acute myeloid leukaemias
    Care, RS
    Valk, PJM
    Goodeve, AC
    Abu-Duhier, FM
    Geertsma-Kleinekoort, WMC
    Wilson, GA
    Gari, MA
    Peake, IR
    Löwenberg, B
    Reilly, JT
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2003, 121 (05) : 775 - 777
  • [6] FLT3 mutation incidence and timing of origin in a population case series of pediatric leukemia
    Chang, Patrick
    Kang, Michelle
    Xiao, Anny
    Chang, Jeffrey
    Feusner, James
    Buffler, Patricia
    Wiemels, Joseph
    [J]. BMC CANCER, 2010, 10
  • [7] Mutation of FLT3 gene in acute myeloid leukemia with normal cytogenetics and its association with clinical and immunophenotypic features
    Chauhan, Pradeep S.
    Bhushan, Bharat
    Mishra, Ashwani K.
    Singh, Laishram C.
    Saluja, Sumita
    Verma, Saurabh
    Gupta, Dipendra K.
    Mittal, Vishakha
    Chaudhry, Sumita
    Kapur, Sujala
    [J]. MEDICAL ONCOLOGY, 2011, 28 (02) : 544 - 551
  • [8] Novel mutations in the FLT3 gene in adult patients with refractory acute myeloid leukemia
    Choi, Y
    Kim, HJ
    Park, BH
    Min, WS
    Kim, CC
    [J]. LEUKEMIA, 2005, 19 (01) : 141 - 143
  • [9] Protein kinases as targets for anticancer agents: from inhibitors to useful drugs
    Fabbro, D
    Ruetz, S
    Buchdunger, E
    Cowan-Jacob, SW
    Fendrich, G
    Liebetanz, J
    Mestan, J
    O'Reilly, T
    Traxler, P
    Chaudhuri, B
    Fretz, H
    Zimmermann, J
    Meyer, T
    Caravatti, G
    Furet, P
    Manley, PW
    [J]. PHARMACOLOGY & THERAPEUTICS, 2002, 93 (2-3) : 79 - 98
  • [10] Fenski R, 2000, BRIT J HAEMATOL, V108, P322